about
X-ray crystallography over the past decade for novel drug discovery - where are we heading next?Structures of the apo and holo forms of formate dehydrogenase from the bacterium Moraxella sp. C-1: towards understanding the mechanism of the closure of the interdomain cleftStructure of anabolic ornithine carbamoyltransferase from Campylobacter jejuni at 2.7 Å resolutionATP-dependent DNA ligase fromThermococcussp. 1519 displays a new arrangement of the OB-fold domainCirculatory zinc transport is controlled by distinct interdomain sites on mammalian albumins.CheckMyMetal: a macromolecular metal-binding validation toolCrystal structure of equine serum albumin in complex with cetirizine reveals a novel drug binding site.Protein purification and crystallization artifacts: The tale usually not told.Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin.Structure of BbKI, a disulfide-free plasma kallikrein inhibitor.Magnesium-binding architectures in RNA crystal structures: validation, binding preferences, classification and motif detection.NADP-Dependent Aldehyde Dehydrogenase from Archaeon Pyrobaculum sp.1860: Structural and Functional Features.Atomic Resolution Crystal Structure of NAD(+)-Dependent Formate Dehydrogenase from Bacterium Moraxella sp. C-1.Structural, Biochemical, and Evolutionary Characterizations of Glyoxylate/Hydroxypyruvate Reductases Show Their Division into Two Distinct Subfamilies.Characterizing metal-binding sites in proteins with X-ray crystallography.Automatic Recognition of Ligands in Electron Density by Machine LearningRefining the macromolecular model – achieving the best agreement with the data from X-ray diffraction experimentCorrigendum to "A transient post-translational modification of active site cysteine alters binding properties of the parkinsonism protein DJ-1" [Biochem. Biophys. Res. Commun. 504 (1) (2018 Sep 26) 328-333]A transient post-translational modification of active site cysteine alters binding properties of the parkinsonism protein DJ-1Glyoxylate reductase as versatile enzymatic system for pharmaceutical and medical useMolecular modeling of formate dehydrogenase: the formation of the Michaelis complexInvestigation of formate transport through the substrate channel of formate dehydrogenase by steered molecular dynamics simulationsFormate dehyrogenase from Soya Glycine max: cloning, expression, properties and structure of the recombinant enzymeRecombinant formate dehydrogenase from Arabidopsis thaliana: Preparation, crystal growth in microgravity, and preliminary X-ray diffraction studyClassification, substrate specificity and structural features of D-2-hydroxyacid dehydrogenases: 2HADH knowledgebaseA close look onto structural models and primary ligands of metallo-β-lactamasesTestosterone meets albumin - the molecular mechanism of sex hormone transport by serum albuminsTrinuclear copper biocatalytic center forms an active site of thiocyanate dehydrogenaseStructural and biochemical analysis of Bacillus anthracis prephenate dehydrogenase reveals an unusual mode of inhibition by tyrosine via the ACT domainThe Integrated Resource for Reproducibility in Macromolecular Crystallography: Experiences of the first four yearsCorrection to: Classification, substrate specificity and structural features of D-2-hydroxyacid dehydrogenases: 2HADH knowledgebasePyrimidine biosynthesis in pathogens - Structures and analysis of dihydroorotases from Yersinia pestis and Vibrio choleraeLigand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank
P50
Q26801307-3891323B-7688-4C07-BA8D-A7E1B1BE02C0Q27658478-32848FF5-9547-40A4-8A0B-77C6A259B82DQ27672025-5747476E-A4F8-4FF2-B5F3-3F28765B6AC9Q27675298-C72FD18E-3434-42B8-8FA0-CE4904A6A542Q30252235-11824C00-6BD4-4FB5-B470-2357D43EDBC7Q30252957-91215ECB-8A4F-45C8-8B7F-49BD40028C80Q30277306-9D28321A-8F5B-4FBC-AD3F-B6D2771E4747Q30277913-841F9D54-311D-48A7-AA3F-6EF3BCBD0A4CQ30278772-571D0C1B-9BD6-4A5B-83BD-E09E84C5C744Q30278887-5B88DB35-B29D-4B54-A1DE-F7278260EFAFQ30300321-ADD627A7-2176-4C2E-9E53-FD669F458AB3Q30354828-EA0353B5-1C14-4682-9E8B-426B18810FC7Q41870705-2228372C-6124-44E1-BE86-978A2D315E07Q48295977-B3055B66-D54C-4948-8979-86E7A88F71F6Q53056707-FCCDE7D0-42D1-4D56-A7F5-676978EBC57CQ56341624-CBCAA762-4C72-48BD-A70C-552B1420E5A8Q56931853-36A7E085-0829-4857-BF28-4DE5B0968D88Q57185978-74D47494-7832-432B-B8DE-38E917DD4F35Q57459054-914881B6-C0E7-45FC-8FCA-71442A9C0CDBQ57459060-A3311D21-E178-4123-986B-C04C788D914AQ57459067-F7C2793F-51AF-4EE9-B062-69B64AB6D4F3Q57459070-9D74627C-0170-4654-AAB6-5AB3D9640544Q57459072-6A5B9DA5-4E77-4882-A2B5-7F438F5C4369Q57459075-4F7F6CEC-148B-476A-A54C-B042B4495560Q60935913-926E3C97-B975-4470-9902-68DB807F385DQ62672932-4F6C0C03-7A52-40E9-B13B-61F1EDDBC8CAQ62674141-F1F08F68-2A4B-47A0-A908-3C333FC60752Q89865138-2FE618CB-05C8-479D-A1AC-C2D2934F28B0Q91372402-88E4E6CF-856A-4777-AF76-A9FC9360AD71Q91454193-DB392F0A-B8B3-4CEB-8DEB-E7B434A24435Q91932355-B8B33D99-9CAE-4467-B041-78314F403591Q92810415-3A77B27A-1D47-4A10-BC0E-D1BC82CD3D01Q94955671-08D1614B-98D0-4479-96F9-A333B2EB634C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ivan G Shabalin
@ast
Ivan G Shabalin
@es
Ivan G Shabalin
@nl
Ivan G Shabalin
@sl
Ivan G. Shabalin
@de
Ivan G. Shabalin
@en
Иван Григорьевич Шабалин
@ru
type
label
Ivan G Shabalin
@ast
Ivan G Shabalin
@es
Ivan G Shabalin
@nl
Ivan G Shabalin
@sl
Ivan G. Shabalin
@de
Ivan G. Shabalin
@en
Иван Григорьевич Шабалин
@ru
altLabel
I G Shabalin
@en
I Shabalin
@en
I. G. Shabalin
@en
I. Shabalin
@en
Ivan G Shabalin
@en
Ivan Grigoryevich Shabalin
@en
Ivan Shabalin
@en
Iwan Grigorjewitsch Schabalin
@de
Iwan Schabalin
@de
Shabalin I
@en
prefLabel
Ivan G Shabalin
@ast
Ivan G Shabalin
@es
Ivan G Shabalin
@nl
Ivan G Shabalin
@sl
Ivan G. Shabalin
@de
Ivan G. Shabalin
@en
Иван Григорьевич Шабалин
@ru
P1053
H-1902-2016
P106
P2002
IvanShabalin3
P21
P31
P496
0000-0003-3955-9242